ASH HIGHLIGHTS 2024 – LYMPHOMA ROUNDTABLE DISCUSSIONS: ECOG-ACRIN EA4151 Phase 3 Randomized Trial

ASH HIGHLIGHTS 2024 – LYMPHOMA ROUNDTABLE DISCUSSIONS: ECOG-ACRIN EA4151 Phase 3 Randomized Trial

ASH HIGHLIGHTS 2024 ROUNDTABLE DISCUSSIONS
Explore more from your favourite experts – click their name to access their entire library of content.
Icon Chair Speaker

Chair

Dr. Carolyn Owen

Icon Chair Speaker

Speaker

Dr. Kerry Savage

Dr. Anca Prica

Studies / Trials Discussed

ECOG-ACRIN EA4151 Phase 3 Randomized Trial

This program has been made possible through unrestricted support from BeiGene, Eli Lilly & Pfizer

Studies/trials discussed:

ECOG-ACRIN EA4151 Phase 3 Randomized Trial
Tagged